Utah Medical Products Inc (UTMD) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Utah Medical Products Inc (US:UTMD), trading at 69.57. In 2025, Utah Medical Products Inc generated $38.52 Million in revenue and $14.32 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Utah Medical Products Inc is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 69.57
- Recent Revenue (2025): $38.52 Million
- Free Cash Flow (2025): $14.32 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.